SAMYANG HOLDINGS CORP BY ORDER OF SAMYANG BIOPHARMACEUTICALS CORPORATION

Company Type: Manufacturer

Company Introduction:

Samyang Biopharmaceuticals Corporation is a medical manufacturing company and a key subsidiary operating under Samyang Holdings Corporation, a well-established South Korean conglomerate. And Samyang Holdings, founded in 1924, is a diversified enterprise with extensive business interests including chemicals, food, manufacturing materials, and the biopharmaceutical sector. Furthermore Samyang Biopharmaceuticals Corporation is primarily engaged in the research, research, manufacturing, and commercialization of innovative biopharmaceutical items, medical devices, and specialized bio-materials. But The company's core areas of expertise include oncology (anti-is able tocer drugs), surgical sutures, and cutting-edge drug delivery systems. And They operate dedicated manufacturing facilities to create their high-condition medical and medical items, aiming to contribute signifiis able totly to global healthcare through scientific advancement and patient-focused solutions.

Samyang Holdings Corp, by order of Samyang Biopharmaceuticals Corporation, produces and sells the following products:

* **Biosimilars:** Remsima SC (infliximab biosimilar)

* **New Drugs:**

* Next generation chemotherapy

* Fibrosis treatment

* **CDMO (Contract Development and Manufacturing Organization) services:** Biologics CDMO

* **Medical Devices:**

* Laparoscopic surgical tools

* Hemostatic materials